Drug Price Trends for NDC 72578-0004

Average Pharmacy Cost for 72578-0004

Drug Name	NDC	Price/Unit ($)	Unit	Date
MEMANTINE HCL 10 MG TABLET	72578-0004-05	0.06682	EACH	2025-04-23
MEMANTINE HCL 10 MG TABLET	72578-0004-14	0.06682	EACH	2025-04-23
MEMANTINE HCL 10 MG TABLET	72578-0004-05	0.06599	EACH	2025-03-19
MEMANTINE HCL 10 MG TABLET	72578-0004-14	0.06599	EACH	2025-03-19

Best Wholesale Price for NDC 72578-0004

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table

Market Analysis and Price Projections for NDC 72578-0004

The pharmaceutical industry is constantly evolving, with drug prices and market trends playing a crucial role in shaping its future. In this comprehensive analysis, we'll delve into the market dynamics and price projections for the drug identified by NDC 72578-0004, which is Memantine Hydrochloride, an oral tablet distributed by Viona Pharmaceuticals Inc[9].

Understanding NDC 72578-0004

Memantine Hydrochloride is a prescription drug used in the treatment of moderate to severe dementia associated with Alzheimer's disease. As an N-methyl-D-aspartate (NMDA) receptor antagonist, it works by regulating the activity of glutamate, a chemical involved in information processing, storage, and retrieval[9].

The Significance of National Drug Codes

National Drug Codes (NDCs) are unique, three-segment numbers assigned by the FDA to human drugs in the United States. They serve as universal product identifiers for drugs and are crucial for various aspects of the pharmaceutical supply chain[5].

"Drug products are identified and reported using a unique, three-segment number, called the National Drug Code (NDC), which is a universal product identifier for human drugs in the United States."[5]

Current Market Position

To understand the market position of Memantine Hydrochloride (NDC 72578-0004), we need to consider several factors:

Market Share

While specific market share data for this particular NDC is not provided in the search results, we can infer some information from general market trends. The pharmaceutical market is highly competitive, with both brand-name and generic versions of drugs vying for market share.

Pricing Trends

Prescription drug prices in the United States have been a subject of significant concern. In 2022, over 3,000 drugs experienced a price increase in January, with an average increase of nearly $150 per drug, representing a 10% increase[4].

Competitive Landscape

Memantine Hydrochloride faces competition from other Alzheimer's treatments, including both brand-name and generic versions. The competitive landscape can significantly impact pricing strategies and market share.

Factors Influencing Price Projections

Several key factors will influence the price projections for NDC 72578-0004:

Historical Price Changes

Historically, the largest number of price increases for prescription drugs occur in January and July each year[4]. This pattern could potentially apply to Memantine Hydrochloride as well.

Market Demand

The demand for Alzheimer's treatments is likely to increase as the global population ages. This could potentially drive up prices for drugs like Memantine Hydrochloride.

Regulatory Environment

Changes in healthcare policies and regulations can significantly impact drug pricing. For instance, new regulations aimed at controlling price increases could affect the pricing strategy for this drug.

Manufacturing Costs

Fluctuations in raw material costs, changes in manufacturing processes, or supply chain disruptions could influence the pricing of Memantine Hydrochloride.

Industry Trends Shaping the Future

The pharmaceutical industry is undergoing significant transformations that could impact the market for drugs like Memantine Hydrochloride:

AI and Data-Driven R&D

85% of biopharma executives plan to invest in data, digital, and AI in R&D for 2025[7]. This could potentially lead to more efficient drug development processes and impact pricing strategies.

Focus on High Unmet Needs

Pharmaceutical companies are increasingly shifting focus to therapy areas with high unmet needs[7]. Alzheimer's disease, being a significant health concern with limited treatment options, could see increased attention and investment.

Supply Chain Optimization

More than 85% of biopharma executives are investing in data, AI, and digital tools to build supply chain resiliency[7]. This could potentially lead to more stable pricing and availability of drugs.

Price Projections for NDC 72578-0004

Based on the available information and industry trends, we can consider several scenarios for the price projections of Memantine Hydrochloride (NDC 72578-0004):

Short-Term Projections

In the short term, we might expect to see price increases in line with industry averages. Given the trend of significant price increases in January and July, Memantine Hydrochloride could potentially see price hikes during these months.

Long-Term Projections

Long-term price projections need to consider broader market trends, including the growth of the biopharma industry, international price comparisons, and regulatory changes. If Memantine Hydrochloride continues to be a key treatment for Alzheimer's disease, it may see price increases above the general inflation rate.

Optimistic Scenario

In an optimistic scenario, prices might remain stable or see a slight increase (around 2-3%) due to market growth and stable demand[6].

Conservative Scenario

A more conservative projection might anticipate larger price increases, potentially in line with the average increases seen in recent years (around 10%)[4].

Impact of International Markets

The pricing of Memantine Hydrochloride in the U.S. should be considered in the context of international markets:

"In 2022, the average price per unit in the U.S. was 5.5 times as high as in the OECD (excluding the U.S.) and 7.7 times as high as in the rest of the world."[4]

This significant price disparity could potentially put pressure on U.S. prices in the long term, especially if policies are implemented to align U.S. drug prices more closely with international markets.

Potential Market Disruptions

Several factors could potentially disrupt the market for Memantine Hydrochloride:

Emergence of New Treatments

The development of new, more effective Alzheimer's treatments could significantly impact the market for existing drugs like Memantine Hydrochloride.

Generic Competition

As patents expire, the entry of generic competitors could put downward pressure on prices.

Policy Changes

Major healthcare policy changes, such as reforms to drug pricing regulations, could have a substantial impact on the pricing and market position of Memantine Hydrochloride.

Strategies for Stakeholders

Given the complex and evolving nature of the pharmaceutical market, various stakeholders should consider the following strategies:

For Pharmaceutical Companies

• Invest in R&D to improve drug efficacy or develop new formulations
• Optimize supply chains to reduce costs and ensure steady supply
• Develop robust pricing strategies that balance profitability with market access

For Healthcare Providers

• Stay informed about pricing trends and alternative treatment options
• Advocate for patients to ensure access to necessary medications
• Consider cost-effectiveness when making treatment decisions

For Patients and Caregivers

• Stay informed about treatment options and their costs
• Explore patient assistance programs or generic alternatives when available
• Advocate for fair drug pricing policies

Future Outlook

The future market for Memantine Hydrochloride (NDC 72578-0004) will likely be shaped by a combination of factors including scientific advancements, regulatory changes, and market dynamics. As the pharmaceutical industry continues to evolve, stakeholders will need to remain adaptable and informed to navigate the changing landscape effectively.

Key Takeaways

• NDC 72578-0004 identifies Memantine Hydrochloride, an oral tablet used in treating Alzheimer's disease.
• Drug prices in the U.S. have seen significant increases, with major hikes often occurring in January and July.
• The pharmaceutical industry is investing heavily in AI and data-driven R&D, which could impact future drug development and pricing.
• Price projections for Memantine Hydrochloride should consider factors such as historical trends, market demand, regulatory environment, and international price comparisons.
• Stakeholders should stay informed about market trends and be prepared for potential disruptions in the pharmaceutical landscape.

FAQs

1. What is NDC 72578-0004? NDC 72578-0004 is the National Drug Code for Memantine Hydrochloride, an oral tablet used in treating moderate to severe dementia associated with Alzheimer's disease.

2. How often do drug prices typically increase? The largest number of price increases for prescription drugs typically occur in January and July each year.

3. What factors influence drug price projections? Key factors include historical price changes, market demand, competition, regulatory environment, and manufacturing costs.

4. How does AI impact the pharmaceutical industry? AI is increasingly being used in R&D processes, potentially leading to more efficient drug development and impacting pricing strategies.

5. How do U.S. drug prices compare to international markets? In 2022, the average price per unit in the U.S. was 5.5 times higher than in OECD countries (excluding the U.S.) and 7.7 times higher than in the rest of the world.

Sources cited:

1. [4]
2. [5]
3. [7]
4. [9]